Organ-on-a-chip technology for nanoparticle research.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Nanoengineering and nanomedicine have rapidly advanced, with engineered nanoparticles showing promise for targeted drug delivery.
• Developing reliable in vitro models is crucial for assessing nanotherapeutic efficacy and safety.
• Conventional preclinical models have limitations in accurately predicting human physiological responses.

Purpose of the Study:

• To review recent applications of organ-on-a-chip technology for in vitro studies of nanoparticles.
• To focus on the use of organ-on-a-chip models for toxicity and efficacy assessment of therapeutic nanoparticles.
• To discuss current challenges and future opportunities for implementing this technology in nanoparticle research.

Main Methods:

• Review of recent scientific literature on organ-on-a-chip applications in nanoparticle research.
• Analysis of studies focusing on toxicity and efficacy assessments of nanotherapeutics.
• Identification of key challenges and future directions in the field.

Main Results:

• Organ-on-a-chip technology provides a promising platform for in vitro nanoparticle evaluation.
• These models can help assess both the efficacy and potential toxicity of nanotherapeutics.
• The technology addresses limitations inherent in traditional preclinical testing models.

Conclusions:

• Organ-on-a-chip technology is a valuable emerging tool for nanomedicine research.
• It enables more accurate in vitro assessment of nanoparticle-based therapies.
• Further development is needed to overcome challenges and fully realize its potential.